ITCI Intra-Cellular Therapies
- 73.120
- -0.890-1.20%
Intra-Cellular Therapies News
Intra-Cellular Therapies | 8-K: Current report
Intra-Cellular Therapies | 8-K: Current report
Intra-Cellular Therapies | 424B5: Prospectus
Intra-Cellular Therapies | 8-K: Current report
Intra-Cellular Therapies | 424B5: Prospectus
Intra-Cellular Therapies | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Intra-Cellular Therapies | 8-K: Current report
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director VAN NOSTRAND ROBERT L
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director RIGGS RORY B
Intra-Cellular Therapies | 8-K: Current report
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Director RIGGS RORY B
Intra-Cellular Therapies | 8-K: Current report
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Mates Sharon
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Hineline Lawrence J.
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Halstead Michael
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Neumann Mark
Intra-Cellular Therapies | 4: Statement of changes in beneficial ownership of securities-Officer Durgam Suresh K.
Intra-Cellular Therapies | 144: Notice of proposed sale of securities pursuant to Rule 144
Intra-Cellular Therapies | 144: Notice of proposed sale of securities pursuant to Rule 144
Intra-Cellular Therapies | 144: Notice of proposed sale of securities pursuant to Rule 144
Analysis
Price Target
No Data
